The psychological and neuropsychological syndrome associated with Long COVID
The project will systematically assess the psychosomatic, psychological and neuropsychological syndrome associated with Long-COVID, to develop a specific treatment strategy to address this syndrome and evaluate the outcomes of said treatment strategy.
What are the project objectives?
Although a considerable number Long-COVID individuals seem to be affected by a syndrome involving symptoms at the psychosomatic, psychological and neuropsychological levels, although not much is known at this stage about the specificity of the syndrome.
This projects aims therefore to:
1
Systematically assess the psychosomatic, psychological and neuropsychological syndrome associated with Long-COVID.
2
Develop a specific treatment strategy to address this syndrome.
3
Evaluate the outcome of this treatment strategy.
What population do we target?
All adults with laboratory-confirmed SARS-CoV-2 infection are eligible to participate in the study project.
Study participants will be recruited directly from the clinical treatment.
Coordinated by



Scientists
- Dr Charles Benoy
- Dr Mark Ritzen
- Prof. Dr. Claus Vögele
Communication contacts
Arnaud D’Agostini
Sabine Schmitz